0 XP   0   0   0

Synaptogenix Inc
Buy or Sell?

I guess you are interested in Synaptogenix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Synaptogenix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Synaptogenix Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Synaptogenix Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Synaptogenix Inc. The closing price on 2022-09-23 was $6.95 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Synaptogenix Inc
Synaptogenix Inc Daily Candlestick Chart

1.1. Profitability of Synaptogenix Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Synaptogenix Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM--275.9%+275.9%
YOY--335.9%+335.9%
5Y--469.8%+469.8%
10Y--549.9%+549.9%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Synaptogenix Inc:

  • The MRQ is -12.7%. Very bad. -2
  • The TTM is 4.6%. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
MRQ-12.7%TTM4.6%-17.3%
TTM4.6%YOY36.8%-32.2%
TTM4.6%5Y10.9%-6.4%
5Y10.9%10Y10.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-9.8%-2.9%
TTM4.6%-8.8%+13.4%
YOY36.8%-9.2%+46.0%
5Y10.9%-11.6%+22.5%
10Y10.9%-12.7%+23.6%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Synaptogenix Inc:

  • The MRQ is -13.0%. Very bad. -2
  • The TTM is 5.1%. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
MRQ-13.0%TTM5.1%-18.1%
TTM5.1%YOY51.1%-45.9%
TTM5.1%5Y16.2%-11.1%
5Y16.2%10Y16.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.0%-11.9%-1.1%
TTM5.1%-11.2%+16.3%
YOY51.1%-10.6%+61.7%
5Y16.2%-13.7%+29.9%
10Y16.2%-14.5%+30.7%

1.2. Operating Efficiency of Synaptogenix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Synaptogenix Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY--306.8%+306.8%
5Y--461.8%+461.8%
10Y--546.8%+546.8%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Synaptogenix Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.662-3.662
YOY-3.692-3.692
5Y-5.743-5.743
10Y-6.919-6.919

1.3. Liquidity of Synaptogenix Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Synaptogenix Inc:

  • The MRQ is 47.220. Very Good. +2
  • The TTM is 36.357. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ47.220TTM36.357+10.862
TTM36.357YOY21.692+14.666
TTM36.3575Y24.501+11.856
5Y24.50110Y24.5010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ47.2205.318+41.902
TTM36.3576.219+30.138
YOY21.6926.366+15.326
5Y24.5016.760+17.741
10Y24.5016.520+17.981
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Synaptogenix Inc:

  • The MRQ is 45.935. Very good. +2
  • The TTM is 35.222. Very good. +2
Trends
Current periodCompared to+/- 
MRQ45.935TTM35.222+10.713
TTM35.222YOY16.568+18.654
TTM35.2225Y22.131+13.091
5Y22.13110Y22.1310.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ45.9354.107+41.828
TTM35.2224.994+30.228
YOY16.5685.257+11.311
5Y22.1315.338+16.793
10Y22.1315.050+17.081

1.4. Solvency of Synaptogenix Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Synaptogenix Inc:

  • The MRQ is 0.021. Very good. +2
  • The TTM is 0.032. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.021TTM0.032-0.011
TTM0.032YOY0.091-0.059
TTM0.0325Y0.052-0.020
5Y0.05210Y0.0520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0210.269-0.248
TTM0.0320.267-0.235
YOY0.0910.296-0.205
5Y0.0520.362-0.310
10Y0.0520.398-0.346
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Synaptogenix Inc:

  • The MRQ is 0.022. Very good. +2
  • The TTM is 0.034. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.022TTM0.034-0.012
TTM0.034YOY0.111-0.078
TTM0.0345Y0.060-0.027
5Y0.06010Y0.0600.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0220.305-0.283
TTM0.0340.303-0.269
YOY0.1110.309-0.198
5Y0.0600.382-0.322
10Y0.0600.436-0.376

2. Market Valuation of Synaptogenix Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Synaptogenix Inc:

  • The EOD is -3.207. Company is losing money. -2
  • The MRQ is -2.395. Company is losing money. -2
  • The TTM is -3.035. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-3.207MRQ-2.395-0.812
MRQ-2.395TTM-3.035+0.641
TTM-3.035YOY-0.773-2.262
TTM-3.0355Y-1.385-1.650
5Y-1.38510Y-1.3850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.207-2.088-1.119
MRQ-2.395-2.275-0.120
TTM-3.035-3.796+0.761
YOY-0.773-4.994+4.221
5Y-1.385-3.642+2.257
10Y-1.385-3.303+1.918
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of Synaptogenix Inc:

  • The MRQ is 0.037. Very good. +2
  • The TTM is 0.042. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.037TTM0.042-0.005
TTM0.0425Y0.0420.000
5Y0.04210Y0.0420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0370.005+0.032
TTM0.0420.020+0.022
5Y0.0420.021+0.021
10Y0.0420.017+0.025

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Synaptogenix Inc:

  • The EOD is 1.671. Good. +1
  • The MRQ is 1.248. Good. +1
  • The TTM is 1.620. Good. +1
Trends
Current periodCompared to+/- 
EOD1.671MRQ1.248+0.423
MRQ1.248TTM1.620-0.373
TTM1.620YOY1.964-0.344
TTM1.6205Y1.303+0.317
5Y1.30310Y1.3030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6711.808-0.137
MRQ1.2481.944-0.696
TTM1.6202.750-1.130
YOY1.9643.492-1.528
5Y1.3032.731-1.428
10Y1.3032.401-1.098

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Synaptogenix Inc.

3.1. Institutions holding Synaptogenix Inc

Institutions are holding 9.185% of the shares of Synaptogenix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31Vanguard Group Inc3.18390216836154688248.9026
2022-03-31Ikarian Capital, LLC2.24990.15615322675975.2167
2022-06-30Cannell Peter B & CO Inc1.11920.01397622000
2022-06-30Geode Capital Management, LLC0.91740.00016247500
2022-03-31Diametric Capital, LP0.3380.098223017-7504-24.5864
2022-03-31State Street Corporation0.295102010012006.3492
2022-06-30Platform Technology Partners0.23540.04531603200
2022-03-31BOOTHBAY FUND MANAGEMENT, LLC0.21490.00261463500
2022-03-31Springbok Capital Management, LLC0.18520.002812614-5290-29.5465
2022-06-30Orion Capital Management LLC0.05870.0163400000
2022-03-31Morgan Stanley - Brokerage Accounts0.050203418-557-14.0126
2022-03-31UBS Group AG0.02930199819980
2022-03-31Tower Research Capital LLC0.00590403-351-46.5517
2022-03-31Wells Fargo & Co0.005904014010
2022-06-30Newbridge Financial Services Group, Inc.0.00440.001230000
2022-03-31Advisor Group Holdings, Inc.0.00150100-198-66.443
2022-03-31First Manhattan Company0.000402500
2022-03-31Rockefeller Capital Management L.P.0.000402500
2022-03-31Royal Bank of Canada000-500-100
2022-03-31Renaissance Technologies Corp000-12700-100
Total 8.89570.3364605825  

3.2. Funds holding Synaptogenix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv2.51130.000117103100
2022-07-31Vanguard Extended Market Index Investor0.63840.00034347700
2022-06-30Fidelity® Extended Market Index0.57210.00073896200
2022-07-29iShares Micro-Cap ETF0.2110.00981436900
2022-06-30Fidelity® Total Market Index0.10960.0001746200
2022-06-30Fidelity® Series Total Market Index0.10610.0001722600
2022-06-30Fidelity® NASDAQ Composite Index®0.07350.0003500400
2022-06-30NT Ext Equity Mkt Idx Fd - L0.06970.0006474900
2022-06-30Northern Trust Extended Eq Market Idx0.06970.0006474900
2022-07-31Schwab Total Stock Market Index0.06710.0002457200
2022-06-30NT Ext Equity Mkt Idx Fd - NL0.05910.0004402800
2022-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.04710.000432052056.8333
2022-06-30Spartan Total Market Index Pool E0.04680.0001318900
2022-07-31State St US Extended Mkt Indx NL Cl C0.03670.0006250000
2022-06-30SSgA U.S. Extended Market Index Class I0.03670.0005250000
2022-07-31Vanguard U.S. Eq Idx £ Acc0.03420.0001232800
2022-06-301290 VT Micro Cap K0.01760.004120112010
2022-07-31State St US Ttl Mkt Indx NL Cl C0.01170.000180000
2022-06-30SSgA U.S. Total Market Index Strategy0.01130.0001771324.3302
2022-06-30Northern Trust Wilshire 50000.00970.00016616610
Total 4.73940.0192322784  

3.3. Insider Transactions

Insiders are holding 17.492% of the shares of Synaptogenix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484
2021-06-14Daniel L AlkonBUY100008.2611484

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Synaptogenix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--4.1604.799-13%8.984-54%8.986-54%8.986-54%
Current Ratio--47.22036.357+30%21.692+118%24.501+93%24.501+93%
Debt To Asset Ratio--0.0210.032-34%0.091-77%0.052-59%0.052-59%
Debt To Equity Ratio--0.0220.034-36%0.111-81%0.060-64%0.060-64%
Eps---0.539-0.542+1%-1.557+189%-1.492+177%-1.492+177%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.671+25%1.2481.620-23%1.964-36%1.303-4%1.303-4%
Pe Ratio-3.207-34%-2.395-3.035+27%-0.773-68%-1.385-42%-1.385-42%
Peg Ratio--0.0370.042-13%--0.042-13%0.042-13%
Price Per Share6.950+25%5.1907.845-34%6.163-16%5.094+2%5.094+2%
Quick Ratio--45.93535.222+30%16.568+177%22.131+108%22.131+108%
Return On Assets---0.1270.046-377%0.368-134%0.109-216%0.109-216%
Return On Equity---0.1300.051-352%0.511-125%0.162-180%0.162-180%
 EOD+1 -2MRQTTM+8 -4YOY+8 -35Y+8 -410Y+8 -4

4.2. Fundamental Score

Let's check the fundamental score of Synaptogenix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.207
Price to Book Ratio (EOD)Between0-11.671
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than145.935
Current Ratio (MRQ)Greater than147.220
Debt To Asset Ratio (MRQ)Less than10.021
Debt to Equity Ratio (MRQ)Less than10.022
Return On Equity (MRQ)Greater than0.15-0.130
Return on Assets (MRQ)Greater than0.05-0.127
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Synaptogenix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.784
Ma 20Greater thanMa 507.960
Ma 50Greater thanMa 1007.301
Ma 100Greater thanMa 2006.371
OpenGreater thanClose6.910
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets29,579
Total Liabilities626
Total Stockholder Equity28,953
 As reported
Total Liabilities 626
Total Stockholder Equity+ 28,953
Total Assets = 29,579

Assets

Total Assets29,579
Total Current Assets29,558
Long-term Assets29,558
Total Current Assets
Cash And Cash Equivalents 28,755
Other Current Assets 804
Total Current Assets  (as reported)29,558
Total Current Assets  (calculated)29,558
+/-0
Long-term Assets
Property Plant Equipment 21
Long-term Assets  (as reported)21
Long-term Assets  (calculated)21
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities626
Long-term Liabilities0
Total Stockholder Equity28,953
Total Current Liabilities
Accounts payable 281
Other Current Liabilities 345
Total Current Liabilities  (as reported)626
Total Current Liabilities  (calculated)626
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -21,171
Other Stockholders Equity 50,124
Total Stockholder Equity (as reported)28,953
Total Stockholder Equity (calculated)28,953
+/-0
Other
Capital Stock1
Cash and Short Term Investments 28,755
Common Stock Shares Outstanding 6,959
Liabilities and Stockholders Equity 29,579
Net Debt -28,755
Net Invested Capital 28,953
Net Tangible Assets 28,953
Net Working Capital 28,932



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
17,898
0
0
29,150
6,751
16,347
32,960
32,359
35,525
32,353
29,579
29,57932,35335,52532,35932,96016,3476,75129,1500017,898
   > Total Current Assets 
17,876
0
0
29,126
6,729
16,326
32,940
32,340
35,504
32,334
29,558
29,55832,33435,50432,34032,94016,3266,72929,1260017,876
       Cash And Cash Equivalents 
17,382
0
0
27,000
5,795
14,848
31,702
31,295
34,214
31,282
28,755
28,75531,28234,21431,29531,70214,8485,79527,0000017,382
       Net Receivables 
0
0
0
862
127
0
0
0
0
0
0
000000127862000
       Other Current Assets 
494
0
0
1,265
934
0
1,238
1,046
1,290
1,052
804
8041,0521,2901,0461,23809341,26500494
   > Long-term Assets 
22
0
0
23
22
21
20
18
20
19
21
21192018202122230022
       Property Plant Equipment 
22
0
0
23
22
21
20
18
20
19
21
21192018202122230022
> Total Liabilities 
479
0
0
1,300
1,612
937
770
1,007
1,995
669
626
6266691,9951,0077709371,6121,30000479
   > Total Current Liabilities 
479
0
0
1,300
1,612
937
770
1,007
1,995
669
626
6266691,9951,0077709371,6121,30000479
       Accounts payable 
413
0
0
1,190
1,260
759
648
935
1,297
401
281
2814011,2979356487591,2601,19000413
       Other Current Liabilities 
66
0
0
110
352
0
122
72
698
268
345
3452686987212203521100066
   > Long-term Liabilities 00000000000
> Total Stockholder Equity
17,419
0
0
27,849
5,139
15,409
32,190
31,351
33,530
31,684
28,953
28,95331,68433,53031,35132,19015,4095,13927,8490017,419
   Common Stock
17,419
0
0
27,849
1
1
1
1
1
1
1
111111127,8490017,419
   Retained Earnings Total Equity00000000000
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
0
0
0
5,139
0
39,168
41,256
47,671
49,103
50,124
50,12449,10347,67141,25639,16805,1390000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-12,618
Operating Income-12,618-12,618
 
Operating Expense (+$)
Research Development4,336
Selling General Administrative8,282
Selling And Marketing Expenses-
Operating Expense12,61812,618
 
Net Interest Income (+$)
Interest Income7
Interest Expense--
Net Interest Income77
 
Pretax Income (+$)
Operating Income-12,618
Net Interest Income7
Other Non-Operating Income Expenses-
Income Before Tax (EBT)12,611-37,848
EBIT - interestExpense = 0
12,611
12,611
Interest Expense-
Earnings Before Interest and Taxes (ebit)012,611
Earnings Before Interest and Taxes (ebitda)5
 
After tax Income (+$)
Income Before Tax12,611
Tax Provision-0
Net Income From Continuing Ops-12,61112,611
Net Income12,611
Net Income Applicable To Common Shares-12,611
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net25,230-7
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DAAPL.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAAPL.CC.

DAAPL.CC Daily Candlestick Chart
UIP.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UIP.CC.

UIP.CC Daily Candlestick Chart
TRC.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRC.CC.

TRC.CC Daily Candlestick Chart
TIX.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIX.CC.

TIX.CC Daily Candlestick Chart
THC.CC
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TERC.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
TBTC.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TBTC.CC.

TBTC.CC Daily Candlestick Chart
SWACE.CC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SWACE.CC.

SWACE.CC Daily Candlestick Chart
START.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of START.CC.

START.CC Daily Candlestick Chart
SNC.CC
1 hour ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SAVG.CC
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SAVG.CC.

SAVG.CC Daily Candlestick Chart
RPZX.CC
1 hour ago

I found you a Golden Cross on the daily chart of RPZX.CC.

RPZX.CC Daily Candlestick Chart
RIO.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RIO.CC.

RIO.CC Daily Candlestick Chart
PYRK.CC
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRK.CC.

PYRK.CC Daily Candlestick Chart
PLAY.CC
1 hour ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
pBTC35A.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of pBTC35A.CC.

pBTC35A.CC Daily Candlestick Chart
PBTC.CC
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PBTC.CC.

PBTC.CC Daily Candlestick Chart
PASC.CC
1 hour ago

I found you a Golden Cross on the daily chart of PASC.CC.

PASC.CC Daily Candlestick Chart
OPCT.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
NCDT.CC
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NCDT.CC.

NCDT.CC Daily Candlestick Chart
MSWAP.CC
1 hour ago

I found you a Death Cross on the daily chart of MSWAP.CC.

MSWAP.CC Daily Candlestick Chart
MERI.CC
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MERI.CC.

MERI.CC Daily Candlestick Chart
MBC.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBC.CC.

MBC.CC Daily Candlestick Chart